Literature DB >> 9097390

Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.

N Ginovart1, L Farde, C Halldin, C G Swahn.   

Abstract

Positron emission tomography was used to examine the in vivo binding of [11C]raclopride to D2-dopamine (DA) receptors in the striatum of two Cynomolgus monkeys after a single dose of reserpine (1 mg/kg, i.v.). A Scatchard procedure was repeated five times to follow D2 receptor density and apparent affinity for 7 weeks after reserpine. Reserpine-induced depletion of DA lead to a marked increase in [11C]raclopride binding, which was still detectable 20 days after treatment. Scatchard analyses indicated that the measured increase in [11C]raclopride binding reflected an increase in receptor affinity but no evident change in receptor density (Bmax). Thus, the increase in [11C]raclopride binding after reserpine should correspond to a reduced competition with endogenous DA for binding to D2 receptors. The results were used to estimate the DA-induced D2 occupancy to be about 40% at physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097390     DOI: 10.1002/(SICI)1098-2396(199704)25:4<321::AID-SYN2>3.0.CO;2-C

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  11 in total

1.  Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.

Authors:  H Tsukada; N Harada; S Nishiyama; H Ohba; T Kakiuchi
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 2.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

3.  Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹⁸F]fallypride.

Authors:  Marta G Vučković; Quanzheng Li; Beth Fisher; Angelo Nacca; Richard M Leahy; John P Walsh; Jogesh Mukherjee; Celia Williams; Michael W Jakowec; Giselle M Petzinger
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

Review 4.  Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism.

Authors:  Nathalie Ginovart
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

5.  Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.

Authors:  Nicholas Seneca; Mette Skinbjerg; Sami S Zoghbi; Jeih-San Liow; Robert L Gladding; Jinsoo Hong; Pavitra Kannan; Edward Tuan; David R Sibley; Christer Halldin; Victor W Pike; Robert B Innis
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

6.  PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.

Authors:  Nicholas T Vandehey; P Charles Garell; Joseph A Hampel; Dhanabalan Murali; Elizabeth M Smith; Richard Davidson; Alexander K Converse; R Jerry Nickles; Bradley T Christian
Journal:  J Neurosci Methods       Date:  2008-09-09       Impact factor: 2.390

7.  A receptor-based model for dopamine-induced fMRI signal.

Authors:  Joseph B Mandeville; Christin Y M Sander; Bruce G Jenkins; Jacob M Hooker; Ciprian Catana; Wim Vanduffel; Nathaniel M Alpert; Bruce R Rosen; Marc D Normandin
Journal:  Neuroimage       Date:  2013-03-01       Impact factor: 6.556

8.  Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.

Authors:  Nicholas Seneca; Sami S Zoghbi; Mette Skinbjerg; Jeih-San Liow; Jinsoo Hong; David R Sibley; Victor W Pike; Christer Halldin; Robert B Innis
Journal:  Synapse       Date:  2008-10       Impact factor: 2.562

9.  Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

Authors:  Ludovic Leriche; Tomas Björklund; Nathalie Breysse; Laurent Besret; Marie-Claude Grégoire; Thomas Carlsson; Frédéric Dollé; Ronald J Mandel; Nicole Déglon; Philippe Hantraye; Deniz Kirik
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

10.  Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.

Authors:  M Lamelle; A Abi-Dargham
Journal:  Dialogues Clin Neurosci       Date:  2000-12       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.